利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

143 条记录 (耗时 0.05 秒)

    C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use
    81.
    发明授权
    C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use 有权
    C5，C6氧环稠合噻嗪二氧化物作为BACE抑制剂，组合物及其用途

    公开(公告)号：US09365589B2

    公开(公告)日：2016-06-14

    申请号：US14653685

    申请日：2013-12-16

    申请人： Merck Sharp & Dohme Corp.

    发明人： Jared N. Cumming ,  David Earl Kaelin, Jr. ,  Jack D. Scott ,  Wen-Lian Wu ,  Duane A. Burnett

    IPC分类号： C07D513/04 ,  C07D471/04 ,  C07D498/04 ,  C07D417/12 ,  C07D417/14

    CPC分类号： C07D513/04

    摘要： In its many embodiments, the present invention provides certain C2-ring-substituted iminothiazine compounds, including compounds Formula (I): (structurally represented) or a tautomers thereof, and pharmaceutically acceptable salts of said compounds and, wherein R1, R2, R3, R4, X, ring A, RA, m, -L1-, and RL are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.

    摘要翻译： 在其许多实施方案中，本发明提供了某些C2-环取代的亚氨基噻嗪化合物，包括式（I）化合物：（结构上被表示）或其互变异构体，以及所述化合物的药学上可接受的盐，其中R1，R2，R3， R4，X，环A，RA，m，-L1-和RL如本文所定义。 本发明的新化合物可用作BACE抑制剂和/或用于治疗和预防与其相关的各种病症。 还公开了包含一种或多种这样的化合物（单独和与一种或多种其它活性剂组合）的药物组合物及其制备和使用方法，包括用于治疗阿尔茨海默氏病的药物组合物。

    Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
    82.
    发明授权
    Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use 有权
    作为BACE抑制剂，组合物及其用途的二氢化二氮杂二恶烷化合物

    公开(公告)号：US08940748B2

    公开(公告)日：2015-01-27

    申请号：US14221644

    申请日：2014-03-21

    申请人： Merck Sharp & Dohme Corp.

    发明人： Jack D. Scott ,  Andrew W. Stamford ,  Eric J. Gilbert ,  Jared N. Cumming ,  Ulrich Iserloh

    IPC分类号： A01N43/54 ,  C07D239/42 ,  C07D417/12 ,  C07C309/30 ,  A61K31/495 ,  C07D239/14

    CPC分类号： A61K31/549 ,  A61K31/00 ,  A61K31/495 ,  A61K31/54 ,  A61K45/06 ,  C07C309/30 ,  C07D213/26 ,  C07D213/89 ,  C07D239/14 ,  C07D285/18 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D417/04 ,  C07D417/10 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04 ,  A61K2300/00

    摘要： In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (“Aβ”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.

    摘要翻译： 在其许多实施方案中，本发明提供了某些亚氨基二嗪二氧化物化合物，包括式（I）化合物：并包括其立体异构体，以及所述化合物立体异构体的药学上可接受的盐，其中R1，R2，R3，R4，R5，R9， 环A，环B，m，n，p，-L 1 - ， - 2 - 和-L 3 - 独立地如本文所定义。 令人惊讶地发现本发明的新型亚氨基二嗪二氧化物化合物表现出预期使其作为BACE抑制剂和/或用于治疗和预防与“淀粉样蛋白”（“A”）生产有关的各种病理学的优点的性质。 还公开了包含一种或多种这样的化合物（单独并与一种或多种其它活性剂组合）的药物组合物，及其制备和用于治疗与淀粉样蛋白β（Aβ）蛋白（包括阿尔茨海默氏病）相关的病理学的方法。